IASLC – International Association for the Study of Lung Cancer
ESMO – European Association of Medical Oncology
UMOS – Udruženje medilkalnih onkologa Srbije
SLD – Srpsko Lekarsko Društvo, Sekcija palijativne medicine (predsednik sekcije), Reginalna lekarska komora Vojvodine
UBS – Udruženje bronhologa Srbije
RUS – Respiratorno Udruženje Srbije

Djekic Malbas J, Kovacevic T, Vukoja M, Bursac D, Bokan D, Stojsic V, Zaric B. Nodule Characteristics, Clinical Risk Factors, and Radiologist Experience as Predictors of Positive Baseline LDCT Screening Results. Healthcare. 2025;13(21):2734

Kontic M, Markovic F,Nikolic N,Samardzic N, Stouanovic G, Simurdic P, Petkov S, Bursac D, Zaric B, Stjepanovic M. Efficacy of Atezolizumab in Subsequent Lines of Therapy for NSCLC Patients: Insights from Real-World Data.CANCERS.2024; 16:.21. –

Kovačević T, Zarić B, Đekić-Malbaša J, Bokan D, Nikolin B, Bursać D, Simurdić P, Stojšić V, Stojanović G, Marić D. Attitudes toward Death among Health Care Professionals in the Balkan Region. Current Oncology. 2024;31(6)3350-60

Lalic N, Bursac D, Bojovic M, Nemet M, Ergelasev I. The importance of re-biopsy in the era of molecular therapy for lung cancer. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO. 2024;152( 3-4):209-213.

Lalic N, Bojovic M, Bursac D, Bokan D, Ceriman-Krstic V, et al.The efficacy outcomes in non-small cell lung cancer patients treated with PD axis inhibitor agents-a population-based study of the Vojvodina region. PATHOLOGY & ONCOLOGY RESEARCH. 2024; 30.

Bursac D, Zaric B, Bokan D, Kovacevic T, Stojsic V, Petkov S, Mitrovic K, Stojanovic G. Mortality of COVID-19 pneumonia during anticancer treatment in lung cancer patients. Vojnosanitetski pregled. 2022;79(5):18

Zarogoulidis P, Christakidis V, Petridis D, Sapalidis K, Kosmidis C, Vagionas A, Perdikouri EI, Hohenforst-Schmidt W, Huang H, Petanidis S, Tsakiridis K, Baka S, Romanidis K, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Boukovinas I, Tolis C, Sardeli C. Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination. Expert Rev Respir Med. 2021;15(5):675-679.

Zarogoulidis P, Huang H, Zhou J, Ning Y, Yang M, Wang J, Zhang R, Bai C, Shen X, Huang Z, Petridis D, Kosmidis C, Kosmidou M, Tsakiridis K, Hohenforst-Schmidt W, Baka S, Petanidis S, Zaric B, Kovacevic T, Stojsic V, Sarcev T, Bursac D, Kukic B, Rapti A, Pantea S, Rogoveanu O, Rogoveanu I, Romanidis K, Kesisoglou I, Ioannidis A, Vagionas A, Sapalidis K. Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons. Expert Rev Med Devices. 2021;18(2):197-201.